[Two years experience with L-DOPA in association with a decarboxylase inhibitor].
D000208:Acute Disease; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy; D009069:Movement Disorders / Q000188:drug therapy; D009325:Nausea / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D014839:Vomiting / Q000188:drug therapy
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine
Deux ans d'expérience avec la L-DOPA associée à un inhibiteur de la décarboxylase.